Document is current

Any future updates will be listed below

Keine Rolle für Temozolomid in der Primärtherapie

Crossref DOI link: https://doi.org/10.1007/s15005-023-3311-y

Published Online: 2023-08-21

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark